Stay updated with breaking news from Asensus Surgical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Asensus Surgical, Inc. announced that it has entered into a secured promissory note with new lender, KARL STORZ SE & Co. KG for gross proceeds of $20,000,000 on April 3, 2024. The Note bears interest...
Asensus Surgical (NYSE:ASXC) announced today that it entered into a non-binding letter of intent for Karl Storz to acquire it.
KARL STORZ to provide up to $20 million in bridge financing...
HC Wainwright restated their buy rating on shares of Asensus Surgical (NYSEAMERICAN:ASXC – Free Report) in a report issued on Friday morning, Benzinga reports. They currently have a $2.00 price objective on the stock. HC Wainwright also issued estimates for Asensus Surgical’s Q1 2025 earnings at ($0.03) EPS, Q2 2025 earnings at ($0.03) EPS, Q3 […]
The past few years have been a topsy-turvy ride for the biotech sector.